Johnson & Johnson has asked the Food and Drug Administration to authorize a booster for people 18 and older six months after initial immunization, with an option to vaccinate after two months.
America's hospitals are already strained from the delta surge. Now they fear they'll be further overwhelmed by pent-up demand for services and a potentially bad flu season.
Many transplant centers require people with alcohol-related liver disease to remain sober for half a year, before becoming eligible for the waiting list for a liver. But this thinking may be changing.
Scientists have created detailed maps of the brain area that controls movement in mice, monkeys and people. The maps could help explain human ailments like Alzheimer's and Lou Gehrig's disease.
As religious exemptions are now being sought in droves, their use raises concerns that they pose a serious public health risk. But some say vaccine mandates are too much, too soon.
A small number of NFL teams are requiring proof of vaccination to attend home games. Some fans say they're willing to give up their tickets rather than get the shot. Others are embracing the move.
A businessman from Dallas got a PCR test for the coronavirus at a suburban emergency room. The charge for his test was "egregious" but not illegal, say health care analysts. Here's what happened.
Fatal drug overdoses, including from meth, have soared. California is preparing to roll out a controversial but proven treatment that involves paying stimulant users small sums of money not to use.
In a first, doctors injected the gene-editing tool CRISPR directly into cells in patients' eyes. The experiment helped these vision-impaired patients see shapes and colors again.
Boosters are available for higher-risk people who got the Pfizer vaccine. But what about people who got the one-shot Johnson & Johnson? Some doctors say they need an extra shot even more urgently.
Dr. Patricia Bath transformed cataract surgery and fought to eradicate preventable blindness. Marian Croak pioneered the technology behind audio- and videoconferencing and text-to-donate services.
The advisory committee's recommendation follows the FDA's authorization of Pfizer vaccine boosters for people 65 and up. Both regulatory moves will inform the U.S. plan to dispense extra doses.
Many K-12 school districts are tapping federal funds to pay for regular surveillance testing of students. It's an effective pandemic tactic when used alongside mask-wearing and other precautions.
